Neurology and Preclinical Neurological Studies - CONy Pro/Con debate

Journal of Neural Transmission

, Volume 120, Issue 2, pp 343-346

First online:

Controversies in neurology, Vienna, 2012: Steroids in bacterial meningitis: no

  • Bettina PfauslerAffiliated withDepartment of Neurology, Medical University Innsbruck
  • , Erich SchmutzhardAffiliated withDepartment of Neurology, Medical University Innsbruck Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


In acute bacterial meningitis long-term morbidity and mortality are still high, in particular, in low and middle income countries where meningococci are the most frequent causative agents of this disease. If at all, dexamethasone has been shown to be helpful in pneumococcal meningitis, i.e., in elderly Europeans and not in adolescent African, Asian or South American patients. Since deranged glucose, in particular, glucose variability and deranged coagulation homeostasis are known to be deleterious in patients with bacterial meningitis, dexamethasone—being capable to cause both—might add to morbidity and mortality. After more than 20 prospective trials evidence still lacks that dexamethasone improves outcome in the majority of patients. Dexamethasone only exerts a positive effect, if given prior to the first dose of antibiotic; therefore, the introduction of empiric antimicrobial chemotherapy into the emergency (= pre-hospital) management of patients with suspected bacterial meningitis, the discussion on dexamethasone in acute bacterial meningitis is rendered almost futile.


Dexamethasone Acute bacterial meningitis Pneumococci Meningococci Glucose Coagulation homeostasis